Press
High-Tech Gründerfonds investing into nfon AG’s telecommunication solution
nfon AG, developer of hosted PBX solutions and provider of integrated communication solutions wins High-Tech Gründerfonds as a lead investor. The patent pending technology and its integration into a coherent marketing concept convinces High-Tech Gründerfonds of the investment.
Jens Blomeyer, Director of Marketing at nfon AG comments „after a successful market launch, the planned investments into further extension of the platform and its usability will help us to extend our technical advanta
Daniel Wall – Controller
Daniel Wall completed his bachelor’s degree in economics at HHU in Düsseldorf at the end of 2021 and immediately afterwards started his master’s degree in business administration – also at HHU.
He has gone through several stations as a working student. From serial purchasing in an industrial group, facultative property insurance in the reinsurance sector, to controlling in an internal shared service center.
In his last position as a working student, he was promoted to “IT Service Controller” after a few months and was commercially responsible for Group-wide IT Service Controlling for almost a year and a half.
His hobbies include sport, especially badminton, and woodworking.
Portfolio
akirolabs
akirolabs, founded in 2021 by Michael Pleuger, Detlef Schultz, Christoph Flöthmann, and Tim Ergenzinger, develops and provides an AI powered SaaS platform for collaborative strategic procurement. akirolabs is based upon a world-class and industry proven strategic procurement process, methodology and toolkit, embedded into an intuitive cross-functional collaboration workflow and enriched with all relevant internal and external business insight. akirolabs’ unique approach delivers “Procuremen
Press
Successful exit for High-Tech Gründerfonds: Fagron acquires HiperScan
High-Tech Gründerfonds invested in technology company HiperScan, a spin-off of the Fraunhofer Institute for Photonic Microsystems, shortly after its founding in 2008Dresden-based HiperScan has established itself as the market leader for raw material identification in German pharmaciesBecoming part of Fagron will help accelerate the international establishment of HiperScan’s technology and promote the adoption of personalized medicine
Bonn, 27 April 2022 – Fagron, a leading gl
Press
Venly Raises 21 Million Euros in Series A to Bring More Users Into Web3
Venly, a blockchain wallet solution, surpasses 2M users to provide frictionless solutions for game publishers and ecommerce businesses worldwide.
April 28th, Antwerp / Berlin—Venly, a major blockchain technology provider from Belgium, today announces it has secured over €21 million (USD$23 million) in Series A funding, led by Courtside Ventures with participation from Transcend Fund, Coinbase Ventures, Tioga Capital, High-Tech Gründerfonds, Fortino, Plug and Play, Leadblock Partners,
Press
Easily improving efficiency: SOTA SOLUTIONS receives seed investment
Software which creates itself and increases profit – this is the successful concept of SOTA SOLUTIONS, which convinced investors in the early stage. The High-Tech Gründerfonds together with the Gundlach Group supports the start-up from Berlin as investors to enter the market of biochemistry and biogas.
SOTA SOLUTIONS develops software which enables to predict and improve complex processes. Those processes can be steps in the biochemistry’s production as well as controlling biogas facilit
Press
MEET YOUR REALITY: HTGF invests in VR startup R3DT
Virtual Reality (VR) software for industrial engineering suitable for everyday use
Virtual prototypes can now be reviewed with bare hands at the push of a button
High-Tech Gründerfonds III as lead investor in the seed financing round
R3DT is CyberLab alumnus and spin-off from the KIT in Karlsruhe
Germany's largest seed investor High-Tech Gründerfonds (HTGF) has acquired a stake in Virtual Reality (VR) start-up R3DT GmbH. The young company from Karlsruhe develops and s
Press
Altavo concludes Series A for the development of its Artificial Voice
February 20, 2024 – Altavo, a startup in AI-based voice rehabilitation founded in 2021, successfully closed its Series A financing round on February 1, 2024. A European consortium led by OCCIDENT is investing € 5.0m in the development of Altavo’s novel Artificial Voice.
Altavo’s Artificial Voice is a medical device designed to help voiceless people, for example after laryngectomy or during mechanical ventilation, regain their own, natural sounding voice. The proprietary “sil
Press
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Abalos Therapeutics announced today a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells generating a strong anti-tumor immune response. The Series A round was co-led by Boehringer Ingelheim Venture Fund (BIVF) and Gruenderfonds Ruhr, with participation from NRW.BANK and High-Tech Gründe
Press
nfon investors go for growth
The investors in the Munich company nfon AG, one of the leading providers of outsourced telephone systems (IP Centrex), have decided together with nfon’s management to commit additional capital to accelerate growth against the backdrop of this year’s positive business performance.
The investors High-Tech Gründerfonds, Earlybird Venture Capital GmbH & Co. KG, MIG Fonds and Bayerische Beteiligungsgesellschaft have, in a further round of financing, made four million euros of capital ava
Press
eBlocker successfully concludes additional financing round with HTGF investment
Hamburg-based start-up eBlocker has secured a seven-figure sum in additional capital. Following the investments of Innovationsstarter Fonds Hamburg II and other renowned private investors, High-Tech Gründerfonds (HTGF) has provided eBlocker with a further investment boost. In addition, eBlocker founder Christian Bennefeld will be taking part in the High-Tech Partnering Conference (HTPC18) on 30 January. At the conference, the Hamburg-born data protection expert will be sharing his expertise on
Blog
Against the tide – HTGF portfolio SciRhom company rewarded for courage with EUR 63 million Series A financing
In July, HTGF portfolio company SciRhom announced one of the largest financing rounds in German biotechnology this year and will soon begin clinical trials of its first drug. The company’s unique therapeutic approach targets a central node of the immune system. In this interview, company co-founder and current SciRhom Managing Director and COO Jens Ruhe, his Co-Managing Director and CEO Jan Poth and Frank Hensel, Principal at HTGF, provide insights into the collaboration that has been in p
Blog
Challenges and highlights of 2020 and an outlook for 2021
Overall, 2020 was a successful year for High-Tech Gründerfonds despite the difficult circumstances. And the seed investor just recently signed off on the best exit in its history. Managing Director Alex von Frankenberg takes a look back at the challenges and highlights of this past year and provides an outlook for 2021.
Alex, congratulations are in order! In summer, your portfolio company MYR received conditional market approval in Europe for the first-ever drug to treat hepatitis&n
Blog
How passion and expertise led to a billion-euro exit
As a High-Tech Gründerfonds (HTGF) partner, Dr. Bernd Goergen has just signed the most successful exit in HTGF history. US pharmaceutical company Gilead Sciences is set to acquire German biotech start-up MYR for roughly EUR 1.15 billion. In this interview, he speaks about the fight against Hepatitis D, drug development and his own personal successes.
Bernd, congratulations are in order! In 2011, HTGF took up a stake in MYR. And now you’re about to close a billion-eur
How passion and expertise led to a billion-euro exit
As a High-Tech Gründerfonds (HTGF) partner, Dr. Bernd Goergen has signed the most successful exit in HTGF history to date. US pharmaceutical company Gilead Sciences acquired German biotech start-up MYR for roughly EUR 1.15 billion at the end of 2020. In this interview, he speaks about the fight against Hepatitis D, drug development and his own personal successes.
In 2011, HTGF took up a stake in MYR. And in 2020 the billion-euro deal took place. And yet you’ve said that there wa
Press
Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration
High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg University. FMP scientists have discovered a “death complex” in neurons whose activation leads to neurodegeneration. With the identification of a novel class of drugs, the FMP has also laid the foundation for successfully combating life-threatening neurological diseases. The financing makes it no